Physician profile
Norwin Bunal
NPI 1730501008
$7,908.63
in general payments reported to CMS, 2019-2025
22 companies · $1,639 in 2025
The $1,639 reported for 2025 was more than what 91% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,221 · 2022: $1,425 · 2023: $1,722 · 2024: $1,902 · 2025: $1,639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,431 · Travel and Lodging: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,430.99 |
| Travel and Lodging | $831.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,092.67 | 2023-2024 | Synergy |
| Amgen INC. | $1,075.10 | 2021-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $826.98 | 2021-2024 | Xarelto |
| Abiomed | $670.98 | 2024-2025 | Impella |
| Astrazeneca Pharmaceuticals Lp | $608.21 | 2022-2025 | Lokelma, Andexxa, Farxiga |
| Shockwave Medical, INC | $518.62 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $469.10 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $430.69 | 2022-2025 | Camzyos |
| Tactile Systems Technology INC | $425.90 | 2021-2024 | Flexitouch Plus, Entre Plus |
| Scpharmaceuticals INC. | $367.47 | 2024-2025 | |
| Esperion Therapeutics, INC. | $293.75 | 2021-2025 | Nexletol |
| Pfizer INC. | $213.72 | 2022-2024 | |
| Cardiva Medical, INC. | $203.85 | 2025 | Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs |
| Novo Nordisk INC | $198.71 | 2021-2024 | Wegovy |
| Chiesi USA, INC. | $142.49 | 2022-2023 | Kengreal |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $92.40 | 2024 | Ffrangio |
| Abbott Laboratories | $74.82 | 2023-2025 | Absolute Pro, Triclip, Cardiomems |
| Kiniksa Pharmaceuticals International, Plc | $53.75 | 2024 | Arcalyst |
| Biohaven Pharmaceutical Holding Company Ltd. | $52.60 | 2022 | |
| Glaxosmithkline, LLC. | $37.56 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.33 | 2025 | |
| Terumo Medical Corporation | $24.93 | 2024 | Azur Cx Detachable |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norwin Bunal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.